Nathalie M. Delzenne, Full Professor, is President of the Louvain Drug Research Institute and is leading the Research Group in Metabolism and Nutrition at the University Catholique de Louvain.
After a PhD in Pharmaceutical sciences obtained in 1991, a post-doctoral certificate in Nutrition (Lausanne, CH), Nathalie Delzenne performed a post-doctoral stay at the Pasteur Institute in Lille (France), working on the molecular aspects of lipoproteins. She then joined the lab of Professor Pascal Ferré (Inserm, Paris) to study nutrient-gene interactions in the regulation of lipid metabolism. She started an academic carrier at UCLouvain and has been a pioneer in the discovery of nutrients (prebiotics) targeting the gut microbiota to control nutritional disorders (obesity and cardiometabolic diseases, cancer cachexia, addiction to alcohol). She has been nominated as a Highly Cited Researcher (Thompson Reuter 2016,2018,2019). She has published more than 300 papers, as first or last author. She has been involved in many international projects in nutrition and health-related microbiota (FP7 MyNewGut project; ERA-HDHL FiberTAG project). She has been awarded international prizes such as the Lucien Dautrebande Award in pathophysiology (2016). She has been invited as a speaker in more than 50 congresses for the last 5 years, including Keystone symposia (one as a scientific organizer in 2018), Sir Cuthbertson lecturer at ESPEN (European society for clinical nutrition and metabolism) (2019), International Congress in Obesity, European Congress for the Study of Diabetes.
She is a member of the Royal Academy of Medicine in Belgium and is a Founding member and Past-President of the Belgian Nutrition Society. She has been involved as an expert in a lot of scientific evaluation committees.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)